NCT05380102 - Pilot Evaluation of an Continuous Contactless Vitals Parameter Monitoring System Dozee VS | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 28, 2022

Primary Completion Date

June 3, 2022

Study Completion Date

June 10, 2022

Conditions

No Specific Medical Conditions or Disease States

Interventions

DEVICE

Telemetry monitoring

All participants will be on standard telemetry monitoring for Heart Rate, Respiration Rate and movements using the gold standard (Electrocardiography and Capnography respectively).

DEVICE

Continuous monitoring through Earlysense

EarlySense (USFDA approved ballistocardiography device) will be placed under the patients mattress to measure Heart Rate, Respiratory Rate and movements

DEVICE

Continuous monitoring through Dozee VS

Dozee VS will be placed under the patients mattress to measure Heart Rate, Respiratory Rate and movements

Trial Locations (1)

98052

Eastside Research Associates, Redmond